RELATO DE EXPERIÊNCIA "INOVASAÚDE": PODCAST EM INOVAÇÕES CLÍNICAS
Bruno de Vasconcelos Braga(Unknown), Diego Cavalcanti Perrelli, Beatriz Silva Lima(University of Lisbon), Fernanda Cristina de Mesquita, VINÍCIUS VASCONCELOS DO AMARAL, João Modesto Filho, MIRELLA PORTELLA SERAFINI, MATHEUS CALIXTO LEMOS, MATHEUS HENRIQUE DE ALMEIDA CASSIMIRO, GABRIEL JOSÉ SOUTO MAIOR DE FRANÇA, MARIA CECÍLIA GOMES DE FREITAS, MARIA FERNANDA MAGALHÃES SANTANA, Luiz Fernando Menezes Soares de Azevedo, MARINA LEÃO DURÃES, ENÉSIO DE LIMA CAVALCANTI FILHO, Maria Helena Mendonça de Araújo, LUCAS DUARTE MARANHÃO
Cited by 0
Related Papers
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
|European Journal of Pharmaceutics and Biopharmaceutics|2016|59
Toxicology and Biodistribution: The Clinical Value of Animal Biodistribution Studies
|Molecular Therapy — Methods & Clinical Development|2018|59
Regulatory Aspects of Oncologicals: Nanosystems Main Challenges
|Advances in delivery science and technology|2014|30
ANÁLISE COMPARATIVA DO USO DE INIBIDORES DA ALFA-GLUCOSIDASE E DE INIBIDORES DA DPP-4 NO TRATAMENTO DA DIABETES TIPO 2
|Brazilian Journal of Implantology and Health Sciences|2024|1